Navigating the procurement of high-purity follistatin online demands strict analytical rigor, lot-specific verification, and explicit compliance with laboratory standards. As an autocrine glycoprotein heavily investigated in TGF-β superfamily signaling models, securing authentic sequence integrity is critical for reproducible preclinical results. PX1 Research delivers USA-manufactured, third-party tested research peptides tailored exclusively for in vitro and animal research protocols.
Navigating the procurement of high-purity follistatin online demands strict analytical rigor, lot-specific verification, and explicit compliance with laboratory standards. As an autocrine glycoprotein heavily investigated in TGF-β superfamily signaling models, securing authentic sequence integrity is critical for reproducible preclinical results. PX1 Research delivers USA-manufactured, third-party tested research peptides tailored exclusively for in vitro and animal research protocols.
Sourcing research-grade follistatin online requires selecting analytical suppliers that provide lot-specific certificates of analysis (COA), high-performance liquid chromatography (HPLC) purity verification exceeding 98%, mass spectrometry molecular weight validation, and quantified endotoxin testing. Follistatin is an autocrine glycoprotein evaluated exclusively in preclinical and in vitro laboratory models.
When procurement officers and principal investigators evaluate sources for follistatin online, verified chemical structure and low microbial contaminant levels take precedence over commercial availability. Because synthesis of complex proteins like follistatin involves complex folding and disulfide bond formation, minor deviations during manufacturing can render a batch bio-inactive or introduce confounding inflammatory responses in cell culture assays. Qualified suppliers maintain complete chain-of-custody documentation, clear lot traceability, and ISO 17025 laboratory verification.
Follistatin (FST) is a single-chain monomeric autocrine glycoprotein expressed across diverse tissue types, including skeletal muscle, pituitary cells, and gonadal tissue. Mechanistically, follistatin functions as a high-affinity antagonist to specific ligands within the Transforming Growth Factor-beta (TGF-β) superfamily. Rather than interacting directly with signaling receptors, follistatin binds directly to circulating or localized growth factors, preventing them from docking to their target cell surface receptors.
The primary primary structure of full-length follistatin contains a high proportion of cysteine residues, creating an intricate network of intrachain disulfide bonds essential for its tertiary conformation. In preclinical models, this structural motif enables follistatin to form an irreversible, high-affinity complex with target molecules, effectively sequestering them away from activin type II receptors (ActRIIA and ActRIIB). Investigators analyzing signal transduction pathways utilize follistatin to map downstream gene expression shifts downstream of receptor blockade.
The predominant focus of follistatin research centers on its potent neutralization of myostatin (Growth Differentiation Factor 8, or GDF-8) and activin A. Myostatin acts as a negative regulator of muscle mass development, activating the intracellular SMAD2/SMAD3 transcription factor pathway to inhibit protein synthesis and promote muscle catabolism. In vitro data indicate that the introduction of recombinant follistatin neutralizes soluble myostatin, blocking SMAD pathway phosphorylation and altering downstream transcription.
Similarly, preclinical studies suggest that follistatin's binding affinity for activin A regulates follicle-stimulating hormone (FSH) secretion in pituitary cell culture models. By inhibiting activin-mediated transcriptional activation, researchers can isolate the role of TGF-β signaling in cellular differentiation, muscular hypertrophic cascades, and fibrotic tissue remodeling. Understanding these distinct binding dynamics requires access to pristine research reagents available through our curated catalog of research peptides.
Follistatin exists in several distinct isoforms generated through alternative splicing and post-translational proteolysis. The most prominent variants evaluated in academic literature include Follistatin-344 (FST-344), Follistatin-315 (FST-315), and Follistatin-288 (FST-288). The precursor protein consists of 344 amino acids; upon C-terminal cleavage, the circulating FST-315 isoform is produced, whereas alternative splicing yields the membrane-bound FST-288 variant.
In laboratory research settings, Follistatin-344 is frequently referenced due to its historical use as the precursor sequence in gene therapy and recombinant expression vectors. FST-344 contains a C-terminal extension that alters heparin-binding capabilities compared to FST-288. Preclinical rodent models investigating localized tissue accumulation versus systemic circulation utilize these subtle structural variations to measure differential clearance rates and localized binding persistence across muscle tissue matrices.
When designing comparative assays evaluating muscle hypertrophy and cellular growth pathways, researchers frequently evaluate follistatin alongside other targeted signaling compounds. For instance, while follistatin acts as an extracellular ligand trap for TGF-β family members, direct anabolic signaling pathways are often probed using IGF-1 LR3 mechanisms or recombinant IGF variants that stimulate the PI3K/Akt/mTOR pathway.
To establish broader context across experimental models, researchers contrast follistatin with selective myostatin inhibitors and peptide modulators within the myostatin pathway inhibition group. While compounds like IGF-1 LR3 1mg push positive protein translation through tyrosine kinase receptor activation, follistatin acts via negative-inhibitor suppression (disinhibiting protein translation by blocking SMAD signaling). Combining or comparing these distinct mechanisms allows laboratories to map complementary cellular networks controlling cell proliferation, satellite cell activation, and extracellular matrix deposition.
Proper handling and reconstitution protocols are vital to preserve the biological activity of lyophilized follistatin. Because follistatin is a complex protein susceptible to physical shear stress and aggregation, researchers must observe standardized sterile lab procedures during preparation. Reconstitution should be performed using sterile Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on downstream assay compatibility requirements.
The diluent should be introduced gently along the glass vial wall rather than sprayed directly onto the lyophilized peptide cake. Gentle swirl mixing is recommended; rigorous vortexing must be avoided to prevent protein denaturation or precipitation. For extended multi-point assays, reconstituting at concentrations above 100 mcg/mL in buffered solutions containing 0.1% Bovine Serum Albumin (BSA) can prevent non-specific adsorption to plastic microcentrifuge tubes and pipette tips.
Lyophilized follistatin supplied by PX1 Research demonstrates high stability when maintained under controlled ambient temperatures during transit. Upon receipt at the research facility, long-term preservation of the un-reconstituted powder requires storage at -20°C or -80°C in a manual defrost freezer. Lyophilized samples stored under desiccated conditions at -20°C remain stable for up to 24 months without significant degradation.
Once reconstituted into aqueous solution, follistatin should be aliquoted into single-use micro-centrifuge tubes to avoid repeated freeze-thaw cycles, which induce mechanical degradation of the tertiary structure. Reconstituted liquid aliquots are stable at 2°C to 8°C for up to 7 days, or up to 3 months when stored frozen at -80°C. Researchers consulting our central research hub can access further environmental stability data regarding protein handling.
Analytical rigor is the cornerstone of repeatable science. When buying follistatin online, research institutions must demand verified analytical reports for every specific production lot. High-Performance Liquid Chromatography (RP-HPLC) provides quantitative data regarding chemical purity, ensuring that side-chain impurities, truncated sequences, and aggregation products do not distort experimental parameters.
Mass Spectrometry (MS) validates the exact molecular weight of the synthesized glycoprotein, confirming correct sequence assembly. Furthermore, because follistatin assays frequently involve sensitive cell culture protocols or live animal models, quantitative endotoxin testing via Limulus Amebocyte Lysate (LAL) assay is mandatory. High endotoxin levels induce inflammatory cytokines in vitro, obscuring true signaling outcomes. PX1 Research mandates that lot-specific COAs confirm purity levels ≥98% and endotoxin content well within strict research thresholds.
The proliferation of online peptide vendors makes distinguishing analytical-grade suppliers from unverified re-sellers critical for institutional research. A reputable supplier operates through certified synthesis facilities and maintains rigorous quality control procedures at every stage of production. PX1 Research manufactures peptides in state-of-the-art facilities compliant with Good Manufacturing Practices (GMP) and ISO 17025 testing standards.
Key criteria for evaluating suppliers include: transparent lot traceability, accessible analytical certificates, domestic US fulfillment to prevent transit degradation, and standardized cold-chain handling protocols. For high-volume academic laboratories or enterprise biotech initiatives seeking bulk procurement, our dedicated wholesale program offers direct access to continuous batch manufacturing and custom analytical documentation.
Follistatin sourced through PX1 Research is strictly designated as a research-grade chemical intended solely for in vitro laboratory research, analytical testing, and preclinical animal studies. It is not licensed, formulated, or intended for human consumption, clinical diagnostic procedures, therapeutic administration, or veterinary use. Principal investigators and laboratory managers must ensure that procurement aligns with local institutional safety committees and institutional oversight guidelines.
Proper disposal of chemical waste, empty vials, and reconstituted solutions must follow standard biosafety level protocols applicable to recombinant proteins and biological reagents. Maintaining clear documentation of usage, storage logs, and lot certificates protects research integrity and ensures compliance with institutional regulatory mandates.
What is the purity level of PX1 Research follistatin?
PX1 Research provides follistatin with a verified purity level of ≥98%, as confirmed by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS) testing.
How is follistatin shipped to prevent temperature degradation?
Follistatin is shipped in a stable, lyophilized (freeze-dried) state from our US distribution centers (CA and AZ). Lyophilized peptides remain highly stable at ambient temperatures during standard express transit.
What analytical documents are provided with follistatin orders?
Every lot of follistatin is accompanied by a downloadable, lot-specific Certificate of Analysis (COA) generated by an independent ISO 17025 accredited laboratory, detailing HPLC chromatograms, mass spec analysis, and endotoxin levels.
What solvent is recommended for reconstituting follistatin in lab settings?
For most cellular assays and binding studies, sterile Bacteriostatic Water or sterile Phosphate-Buffered Saline (PBS, pH 7.4) is recommended. Adding 0.1% BSA can prevent peptide adherence to container surfaces.
What is the difference between Follistatin-344 and Follistatin-315?
Follistatin-344 is the full-length precursor sequence commonly utilized in recombinant research vectors, whereas Follistatin-315 is the circulating isoform derived after C-terminal processing.
What are the recommended storage conditions for lyophilized follistatin?
Un-reconstituted lyophilized follistatin should be stored in a freezer at -20°C or -80°C in a desiccated environment to maintain long-term stability for up to 24 months.
How low are the endotoxin levels in PX1 Research follistatin lots?
Our follistatin lots undergo rigorous LAL endotoxin testing to ensure minimal endotoxin contamination (typically <0.1 EU/μg), protecting sensitive in vitro assays from non-specific inflammatory signaling.
Is follistatin approved for clinical or veterinary applications?
No. Follistatin supplied by PX1 Research is strictly for in vitro laboratory research and preclinical testing. It is strictly not for human, clinical, therapeutic, or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.